Recently, mutant WT1 has been also associated with NPM1 as secondary mutations; while when WT1 occurs as a secondary mutation, the most common dominant alterations are in DNMT3A, which also negatively affects prognosis of AML patients, PHF6, FLT3, and CEBPA [26]. The gene discussed is WT1; the disease is acute myeloid leukemia.